NCT06294782

PrOsPective Cohort Study for STereotactic Arhythmia Radioablation (STAR) of Refractory Ventricular Tachycardia

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: University of Turin, Italy · Academic / Other
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

This is a multicenter, interventional study. The study will enroll patients that fulfill the inclusion criteria over a 33-month period. Considering the small number of patients who will meet the study criteria, it is also possible to include retrospective patients who already underwent STAR (for instance, as part of a compassionate program) if they meet all the inclusion and exclusion criteria as well as the treatment planning standardized requirements and sign their consent to this trial. All patients prospectively enrolled will undergo a flow of investigations following a standardized approach. ICD programming will be standardized.

Conditions

• Refractory Ventricular Tachycardia

Interventions

Type	Name	Description
RADIATION	STereotactic Arhythmia Radioablation (STAR)	STereotactic Arhythmia Radioablation (STAR)

Timeline

• Start date: 2022-04-15
• Primary completion: 2025-02-01
• Completion: 2025-02-01
• First posted: 2024-03-06
• Last updated: 2024-03-06

Locations

1 site across 1 country: Italy